146 related articles for article (PubMed ID: 2696027)
1. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Goldhirsch A; Gelber RD
Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
[No Abstract] [Full Text] [Related]
2. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
Jonat W; Kaufmann M; Abel U
Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
[No Abstract] [Full Text] [Related]
3. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Gelber RD
Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
[No Abstract] [Full Text] [Related]
4. Adjuvant chemo- and endocrine therapy alone or in combination in premenopausal patients (GABG Trial 1).
Kaufmann M; Jonat W; Abel U
Recent Results Cancer Res; 1989; 115():118-25. PubMed ID: 2696024
[No Abstract] [Full Text] [Related]
5. Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Goldhirsch A; Castiglione M; Gelber RD
Lancet; 1990 May; 335(8697):1099-100. PubMed ID: 1970400
[No Abstract] [Full Text] [Related]
6. The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Castiglione-Gertsch M; Johnsen C; Goldhirsch A; Gelber RD; Rudenstam CM; Collins J; Lindtner J; Hacking A; Cortes-Funes H; Forbes J
Ann Oncol; 1994 Oct; 5(8):717-24. PubMed ID: 7826904
[TBL] [Abstract][Full Text] [Related]
7. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Goldhirsch A
Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355
[No Abstract] [Full Text] [Related]
8. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Ludwig Breast Cancer Study Group
Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Goldhirsch A; Gelber R
NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
[TBL] [Abstract][Full Text] [Related]
11. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptors. An update and application.
Hubay CA; Arafah B; Gordon NH; Guyton SP; Crowe JP
Surg Clin North Am; 1984 Dec; 64(6):1155-72. PubMed ID: 6393400
[TBL] [Abstract][Full Text] [Related]
13. Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Goldhirsch A; Gelber RD
Recent Results Cancer Res; 1989; 115():43-53. PubMed ID: 2696040
[No Abstract] [Full Text] [Related]
14. Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Pearson OH; Hubay CA; Gordon NH; Marshall JS; Crowe JP; Arafah BM; McGuire W
Cancer; 1989 Nov; 64(9):1819-23. PubMed ID: 2790695
[TBL] [Abstract][Full Text] [Related]
15. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Gelber RD; Goldhirsch A
J Clin Oncol; 1986 Dec; 4(12):1772-9. PubMed ID: 3783203
[TBL] [Abstract][Full Text] [Related]
16. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Stewart HJ
Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
[No Abstract] [Full Text] [Related]
17. The role of adjuvant endocrine therapy in primary breast cancer.
Baum M; Ebbs SR
Recent Results Cancer Res; 1989; 115():136-43. PubMed ID: 2696026
[No Abstract] [Full Text] [Related]
18. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
[No Abstract] [Full Text] [Related]
20. How to improve adjuvant treatment results in postmenopausal patients.
Mouridsen HT
Recent Results Cancer Res; 1989; 115():144-52. PubMed ID: 2533698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
